Speaker illustration

Professor Jose Ramon Lopez-Minguez

University Hospital of Badajoz, Badajoz (Spain)

Reduction of major adverse and major cardiovascular events in patients with atrial fibrillation and stent implantation treated with left atrial occlusion device vs oral anticoagulants strategy.

Event: ESC Congress 2022

Topic: Left Atrial Appendage (LAA) Closure

Session: Pharmacology and bleeding/ischaemica trade-off

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb